Low-dose amitriptyline in irritable bowel syndrome: ready for primary care?

Niek de Wit*, Daniel Keszthelyi

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)1727-1728
Number of pages2
JournalLancet
Volume402
Issue number10414
DOIs
Publication statusPublished - 11 Nov 2023

Keywords

  • Humans
  • Amitriptyline/therapeutic use
  • Irritable Bowel Syndrome/drug therapy
  • Analgesics, Non-Narcotic
  • Diarrhea
  • Primary Health Care

Cite this